Merck, known as MSD outside the U.S. and Canada, is an innovative, global healthcare leader that is committed to improving health and well-being around the world. We continue to focus our research on conditions that affect millions of people globally—diseases like Alzheimer’s, diabetes and cancer—while expanding our strengths in areas like vaccines and biologics. We’re applying our global reach, financial strength and scientific excellence to do more of what we’re passionate about: improving health and improving lives.
Corporate Responsibility at Merck
At Merck, corporate responsibility is our commitment to discovering innovative solutions to the world’s greatest health challenges while growing our business in a sustainable way. It is at the heart of our company’s mission to discover, develop and provide innovative products and services that save and improve lives, and it underscores our commitment to developing and rewarding our employees, protecting the environment, and operating with the highest standards of ethics and transparency.
About Our Reporting
As part of our commitment to be open and transparent about our business activities, we report on our corporate responsibility performance annually. This Executive Summary contains highlights from our complete 2013 online responsibility report, where you can find detailed performance data and key performance indicators from our worldwide operations.
Forward Looking Statement
This communication includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck’s 2013 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
Copyright © 2009-2014 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.